Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon next post House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’ You may also like Investing in Uranium ETFs: 9 Options for Uranium... May 10, 2025 Noble Announces Results of 2025 Shareholder Meeting February 28, 2025 Silver47 Announces Closing of $23 Million Brokered LIFE... September 16, 2025 Mawson Finland Closes IPO and Announces Listing on... August 23, 2024 Walker Lane Resources October 2, 2025 IBN Announces Latest Episode of The MiningNewsWire Podcast... July 24, 2025 Silver Crown Confirms Receipt of Royalty Payments and... March 21, 2025 Grande Portage Resources Initiates Sensor-Based Ore Sorting Testwork January 8, 2025 Prismo Metals Announces Closing of Upsized Private Placement... July 19, 2025 Constellation to Revive Three Mile Island, Sell Power... September 24, 2024